Titlebook: Nanoformulations in Human Health; Challenges and Appro Sushama Talegaonkar,Mahendra Rai Book 2020 Springer Nature Switzerland AG 2020 nanot

鳥場

書目名稱Nanoformulations in Human Health影響因子(影響力)




書目名稱Nanoformulations in Human Health影響因子(影響力)學(xué)科排名




書目名稱Nanoformulations in Human Health網(wǎng)絡(luò)公開度




書目名稱Nanoformulations in Human Health網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Nanoformulations in Human Health被引頻次




書目名稱Nanoformulations in Human Health被引頻次學(xué)科排名




書目名稱Nanoformulations in Human Health年度引用




書目名稱Nanoformulations in Human Health年度引用學(xué)科排名




書目名稱Nanoformulations in Human Health讀者反饋




書目名稱Nanoformulations in Human Health讀者反饋學(xué)科排名

linguistics

Cougar

Preformulation Challenges: The Concept Behind the Selection, Design and Preparation of Nanoformulatinal dosage forms as they provide improved drug solubility, bioavailability, drug stability under adverse external or physiological conditions, controlled drug release for prolonged action and target specificity using ligand binding and many more. Multiple essential aspects must be carefully studied

Indicative

Theranostics Nanoformulations: Merging Diagnostics and Nanotherapeutics applications, theranostics has gained profound attention from researchers worldwide. More recently, researchers have attempted to augment the paradigm with the concept of “nanotheranostics,” which offers multimodal medical and biomedical applications. “Nanotheranostics” are specially devised drug d

foppish

overshadow

Conventional and Nonconventional Approaches to Site-Specific Targeting of Nanotherapeutics in Some Irapeutics to reach the diseased sites at an optimum concentration, lack of patient-friendly delivery strategies, and inability of delivery strategies to penetrate and/or release the therapeutic payload at the diseased sites, keeping the normal cells unaffected, are some of the reasons which demand a

冰雹

Recent Developments and Challenges in Nanoformulations Targeting Various Ailments of the Colon attention is required as the colon is the distal-most part of the gastrointestinal system. Also, a drug has to face a wide range of pH conditions before reaching the colon as it varies significantly, starting from 1.2 to 2.0 (acidic) in the stomach, 4.5–6.8 in the small intestine and 7–7.4 (basic)

套索

oncologist

Recent Advances in Nanocarrier-Based Brain-Targeted Drug Delivery for Effective Treatment of Centralonventional drug delivery systems are having limited adequacy to assess the restrictions posed by the imperative blood-brain barrier. Numerous drugs designed for the treatment of various disorders are unable to permeate the BBB. This hampers their ability to effectively reach in the brain. Most of t

engagement